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The stimulation of vascular endothelial growth factor receptor-2 (VEGFR-2) by tumor-derived
VEGF represents a key event in the initiation of angiogenesis. In this work, we report that
VEGFR-2 is localized in endothelial caveolae, associated with caveolin-1, and that this complex is
rapidly dissociated upon stimulation with VEGF. The kinetics of caveolin-1 dissociation correlated
with those of VEGF-dependent VEGFR-2 tyrosine phosphorylation, suggesting that caveolin-1
acts as a negative regulator of VEGF R-2 activity. Interestingly, we observed that in an overex-
pression system in which VEGFR-2 is constitutively active, caveolin-1 overexpression inhibits
VEGFR-2 activity but allows VEGFR-2 to undergo VEGF-dependent activation, suggesting that
caveolin-1 can confer ligand dependency to a receptor system. Removal of caveolin and VEGFR-2
from caveolae by cholesterol depletion resulted in an increase in both basal and VEGF-induced
phosphorylation of VEGFR-2, but led to the inhibition of VEGF-induced ERK activation and
endothelial cell migration, suggesting that localization of VEGFR-2 to these domains is crucial for
VEGF-mediated signaling. Dissociation of the VEGFR-2/caveolin-1 complex by VEGF or cyclo-
dextrin led to a PP2-sensitive phosphorylation of caveolin-1 on tyrosine 14, suggesting the
participation of Src family kinases in this process. Overall, these results suggest that caveolin-1
plays multiple roles in the VEGF-induced signaling cascade.
INTRODUCTION
Angiogenesis, the growth of novel capillaries from preexist-
ing vessels, is essential for a number of physiological pro-
cesses such as wound healing, the female reproductive cycle,
embryonic development, organ formation, tissue regenera-
tion, and tissue remodeling (Folkman, 1995). However, un-
der pathological conditions, uncontrolled angiogenesis sus-
tains the progression of many diseases, including diabetic
retinopathy, psoriasis, rheumatoid arthritis, and tumor
growth (Folkman, 1995). In the latter condition, numerous
studies have provided evidence that tumor growth and
metastasis are angiogenesis dependent (Hanahan and Folk-
man, 1996). On oxygen and nutrient deprivation, tumor cells
promote neovascularization by inducing the expression of
angiogenic cytokines such as the vascular endothelial
growth factor (VEGF). VEGF is a potent and unique angio-
genic protein that induces endothelial cell (EC) proliferation,
EC migration, and vascular permeability, and acts as a cru-
cial survival factor for endothelial cells (Gerbert et al., 1998).
For these reasons, interfering with VEGF’s biological effects
to block tumor angiogenesis has received considerable at-
tention in recent years (Schlaeppi and Wood, 1999), and a
number of agents that interfere with VEGF-mediated bio-
logical events are currently being tested in clinical trials
(Mendel et al., 2000).
At the endothelial cell surface, VEGF binds with high
affinity to at least two distinct vascular endothelial growth
factor receptors: VEGFR-1, also known as fms-like tyrosine
kinase (Flt-1) and VEGFR-2, also known as fetal liver kinase
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(Flk-1/KDR; Thomas, 1996). In adult cells, the mitogenic and
chemotactic effects of VEGF appear mainly to be mediated
by VEGFR-2 (Waltenberger et al., 1994). The activation of
VEGFR-2 induces dimerization and transphosphorylation of
the receptors, followed by tyrosine phosphorylation and/or
activation of several downstream substrates, including the
second messenger-producing enzymes phospholipase C
and phosphatidylinositol 3-kinase (Guo et al., 1995; Xia et al.,
1996), p120GAP (Guo et al., 1995), the adaptor proteins Nck,
Grb2, and Shc (Guo et al., 1995; Kroll and Waltenberger,
1997), the tyrosine phosphatases SHP1 and SHP2 (Kroll and
Waltenberger, 1997), and the cytoskeleton-associated pro-
teins focal adhesion kinase (FAK) and paxillin (Abedi and
Zachary, 1997), these events leading to the activation of the
extracellular-signal regulated kinase and p38 stress-acti-
vated protein kinase pathways (Kroll and Waltenberger,
1997; Rousseau et al., 2000).
In spite of these advances, the mechanisms underlying the
regulation of VEGFR-2 activity remain poorly understood.
The EC response to VEGF is increased by cell attachment to
vitronectin, a specific substrate for the v3 integrin (Borges
et al., 2000), a process possibly involving association of this
integrin with VEGFR-2. Neuropilin-1, a coreceptor of
VEGFR-2, also increases VEGF-induced signaling by trans-
ferring VEGF onto VEGFR-2 (Gitay-Goren et al., 1992). Re-
cently, we reported that inhibition of RhoA activity mark-
edly reduced VEGFR-2 activity and downstream signaling
(Gingras et al., 2000). Interestingly, most of these proteins
have been shown to be localized within small invaginations
of plasma membrane (caveolae), suggesting a role for caveo-
lae in the activation and regulation of the VEGF-dependent
signaling pathway (Anderson, 1998).
Caveolae domains are found in most cell types, particu-
larly in terminally differentiated cells such as adipocytes,
muscle cells, and EC. They are rich in cholesterol, sphingo-
myelin, and glycosphingolipids, which contributes to their
characteristic low buoyant density and insolubility in deter-
gents (Anderson, 1998). The maintenance of cholesterol lev-
els is essential for functional caveolae (Chang et al., 1992;
Schnitzer et al., 1994) and depends, in part, on the interaction
of cholesterol with caveolin-1, a major caveolae component
(Smart et al., 1996). Caveolin-1 is also involved in the regu-
lation of signaling activity via a direct interaction of its
scaffolding domain, corresponding to amino acids 82
through 101, with a consensus sequence present in several
signaling proteins, including EGF and PDGF receptors, the
kinases Src and Fyn, and heterotrimeric G-proteins (Li et al.,
1995, 1996; Couet et al., 1997b; Yamamoto et al., 1999). Two
related caveolin-binding motifs (AXAXXXXA and AXXXX-
AXXA, where A is an aromatic amino acid Trp, Phe or Tyr)
have been identified, and these motifs exist within most
caveolae-associated proteins (Couet et al., 1997a).
Interestingly, the interaction of caveolin with signal trans-
ducing proteins that contain these motifs has been shown to
inhibit the activity of these proteins. Given the role of these
proteins in cell growth and mitogenesis, the negative regu-
latory activity of caveolin-1 suggests that it may act as a
putative tumor suppressor (Galbiati et al., 1998; Wiechen et
al., 2001). Consistent with this hypothesis, the caveolin-1
gene was localized to a suspected tumor suppressor locus in
mice and humans (7q31.1/D7S522) that is deleted in a num-
ber of human cancers (Engelman et al., 1999). In addition,
caveolin-1 expression is reduced or absent in NIH 3T3 cells
transformed by activated oncogenes such as v-Abl, Bcr-Abl
or H-Ras [G12V], and caveolae are absent from these trans-
formed cells (Koleske et al., 1995). Moreover, antisense-me-
diated reduction of caveolin-1 levels in normal NIH 3T3 cells
leads to hyperactivation of the p42/44 mitogen-activated
protein kinase cascade, anchorage-independent growth, and
tumor formation in nude mice (Galbiati et al., 1998). In
addition, caveolin-1 expression in a metastatic adenocarci-
noma cell line inhibits EGF-stimulated lamellipod extension
and cell migration (Zhang et al., 2000).
In addition to its role in tumor cell biology, there is in-
creasing evidence that caveolin-1 may also play an impor-
tant role in angiogenesis. Incubation of endothelial cells with
VEGF leads to a marked down-regulation of both caveolae
and caveolin-1 levels (Liu et al., 1999), and overexpression of
caveolin-1 blocks VEGF-dependent activation of Elk-1 pro-
motor activity (Liu et al., 1999). Disruption of the caveolin-1
gene resulted in uncontrolled EC proliferation in vivo (Drab
et al., 2001; Razani et al., 2001), as well as the suppression of
capillary-like tube formation in vitro (Griffoni et al., 2000),
further supporting the importance of caveolin-1 in EC func-
tion. However, the mechanisms by which caveolin-1 regu-
lates VEGF-induced angiogenesis remain largely unknown.
In this work, we present evidence that VEGF-induced sig-
naling is initiated in low-density caveolar membrane do-
mains and that caveolin-1 may play an important role in this
pathway by acting both as a negative regulator of VEGFR-2
activity under resting conditions and as a substrate that is
tyrosine phosphorylated under activating conditions. These
results provide important information on the mechanisms




Cell culture media were obtained from Life Technologies (Burling-
ton, Ontario, Canada) and serum was purchased from Hyclone
Laboratories (Logan, UT). Electrophoresis reagents were purchased
from Bio-Rad (Mississauga, Ontario, Canada). mAb A3, directed
against VEGFR-2, mAbs against Fyn (sc-434) and RhoA (sc-418), as
well as the monoclonal antiphosphotyrosine antibody PY99 were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). PAbs
against neuropilin-1 (sc-7239), FAK (sc-557), RhoB (sc-180), pAbs
N-998 (sc-505), and C-1158 (sc-504), directed against VEGFR-2, and
agarose-conjugated pAbs against caveolin-1 (sc-894), VEGFR-2 (sc-
504), and c-src (sc-19) were also purchased from Santa Cruz Bio-
technology. mAbs against ACE and v integrin, and pAb against 3
integrin were from Chemicon International (Temecula, CA). mAbs
against eNOS (N30020), caveolin-1 (C37120), paxillin (P13520),
phosphocaveolin (P-Tyr 14 and C91520), and pAb against caveolin
(C13630) were from Transduction Laboratories (Lexington, KY).
mAbs against Cbl (no. 05-44) and Src (no. 05-184) were from Upstate
Biotechnology (Lake Placid, NY). A mAb against pan Ras (Ab3) was
from Calbiochem (La Jolla, CA), and a mAb against -cop (G2279)
was from Sigma-Aldrich Canada (Oakville, Ontario, Canada). Poly-
clonal anti-Src [pY 529] (44-662Z) was obtained from BioSource
International (Camarillo, CA). Anti-mouse and anti-rabbit immuno-
globulin (Ig) G horseradish peroxidase-linked secondary antibodies
were purchased from Jackson ImmunoResearch Laboratories (West
Grove, PA) and enhanced chemiluminescence (ECL) reagents were
from Amersham Pharmacia Biotech (Baie d’Urfé, Québec, Canada).
Human recombinant VEGF was obtained from R&D Systems (Min-
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neapolis, MN). PP2 was purchased from Calbiochem. Micro bicin-
choninic acid protein assay reagents were from Pierce (Rockford,
IL). All other reagents were from Sigma-Aldrich Canada.
Cell Culture
Bovine aortic endothelial cells (BAEC) were kindly provided by Dr.
R. Sauvé (Université de Montréal). The cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) with low glucose,
containing 10% heat-inactivated calf serum (Hyclone Laboratories),
100 U/ml penicillin, and 100 g/ml streptomycin and were used
between passages 9 through 20. For experimental purposes, cells
were plated in 100-mm plastic dishes at 5000 cells/cm2 and were
grown to confluence in a humidified atmosphere containing 5% CO2
and 90% air at 37°C. The endothelial cell (EC) line ECV304 was
purchased from the American Tissue Culture Collection (Manassas,
VA) and the human embryonal kidney cell line 293T was kindly
provided by Dr M. Park (McGill University, Montreal, PQ). ECV304
cells were maintained in medium M199 containing 5% heat-inacti-
vated calf serum, and 293T cells were maintained in DMEM high
glucose containing 10% fetal bovine serum.
Caveolae Isolation
Caveolae membranes were prepared by the method of Smart et al.
(1995) with minor modifications. ECV304 EC grown to near conflu-
ence in 175-mm2 flasks were serum-starved by a 48-h incubation in
serum-free M199 medium, scraped into 10 ml of homogenization
buffer (Buffer A: 250 mM sucrose, 1 mM EDTA, and 20 mM Tricine,
pH 7.4), and collected by low-speed centrifugation. The cells were
resuspended in 2 ml of buffer A and homogenized with 20 stokes of
a motor-driven Teflon-glass Potter homogenizer. After removal of
cellular debris by low-speed centrifugation, the postnuclear super-
natant was layered on top of 23 ml of 30% (vol/vol) Percoll in buffer
A and centrifuged at 84,000g for 30 min. The plasma membrane
fraction was collected and diluted to 7 ml with buffer A. The
resulting membranes were sonicated (six bursts of 15 s at 50%
maximal power) and mixed with 6.44 ml of 50% Optiprep in buffer
B (0.25 M sucrose, 6 mM EDTA, and 120 mM Tricine, pH 7.4) and
0.56 ml of buffer A. The resulting mixture (23% final Optiprep
concentration) was placed at the bottom of a centrifuge tube and a
linear 20% to 10% Optiprep gradient was layered onto the mem-
branes. After overnight centrifugation at 52,000g, the top 16 ml of
the gradient were collected, mixed with 14 ml of 50% Optiprep in
buffer B, and overlaid with 3.5 ml of 15% Optiprep and 1.75 ml of 5%
Optiprep, both in buffer A. The mixture was centrifuged at 52,000g
for 4 h and the material at the 5% interface was collected. The
purified membranes were collected by ultracentrifugation, resus-
pended in 20 mM Tris-HCl buffer, pH 7.4, and stored at 80°C.
Noncaveolae membranes were obtained after ultracentrifugation of
nonpooled fractions of the linear and discontinued Optiprep gradi-
ents. Tyrosine phosphorylation activities of the membranes were
not affected by the storage conditions (up to 1 month).
Caveolae were also purified using a hyperosmotic carbonate
method described previously (Song et al., 1996). Briefly, confluent
BAEC cells cultured in 100-mm2 dishes were treated as described
above and were scraped into 2 ml of 0.5 M sodium carbonate (pH
11) and homogenized extensively using a Polytron (three 15-s bursts
at medium speed) followed by sonication (five 15-s bursts at 50% of
maximal power). The resulting homogenate was brought to 45%
sucrose by the addition of 2 ml of 90% sucrose in Mes-buffered
saline (MBS; 25 mM Mes, pH 6.5 and 150 mM NaCl) and overlaid
with two layers of 35% and 5% sucrose in MBS containing 0.25 M
carbonate (4 ml each). The gradient was then centrifuged at 200,000
g for 18 h using a rotor (SW41Ti; Beckman Instruments, Fullerton,
CA). For analysis of the resulting gradient, 1-ml fractions were
collected from the top to the bottom of the gradient. The light-
density fractions were pooled, diluted in 10 mM Tris-HCl (pH 7.5),
and centrifuged at 100,000g.
VEGF Stimulation of Caveolae Membranes
Caveolae membranes (250 ng protein) were preincubated at 4°C for
30 min in 1 MEM (pH 7.4) containing 250 g/ml bovine serum
albumin, 2 mM activated sodium orthovanadate, 1 mM zinc acetate,
10 mM NaF, 10 mM MgCl2, and a protease inhibitor cocktail (100
g/ml leupeptin, 100 g/ml pepstatin A, 20 g/ml antipain, 10
mM benzamidine, and 1 mM Pefabloc), in the presence of 0 to 100
ng/ml human recombinant VEGF (R&D Systems). The preincuba-
tion mixture was placed at 30°C for 2 min and the reaction was
started by the addition of ATP (1 mM final concentration). The
mixtures were incubated at 30°C for 5 min and the reactions were
stopped by the addition of fivefold concentrated Laemmli sample
buffer.
VEGF Stimulation of EC
BAEC grown to confluence were serum-starved by an 18-h incuba-
tion in serum-free DMEM, followed by incubation for 1 to 30 min at
37°C in 2 ml of serum-free DMEM containing 50 ng/ml human
recombinant VEGF. In some experiments, cells were treated for 2 h
with PP2 or for 60 min with 10 mM -cyclodextrin (CD) before
stimulation with VEGF. Cells were replenished with cholesterol by
incubation in the presence of 16 g/ml cholesterol and 0.4% CD
(Furuchi and Anderson, 1998). After VEGF treatment, cells were
washed once with phosphate-buffered saline (PBS) containing 1 mM
sodium orthovanadate and were incubated in the same medium for
1 h at 4°C. The cells were solubilized on ice in lysis buffer (150 mM
NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.5%
Nonidet P-40, 1% Triton X-100, and 60 mM n-octylglucoside) con-
taining 1 mM sodium orthovanadate. The cells were then scraped
from the culture dishes and the resulting lysates were clarified by
centrifugation at 10,000g for 10 min. Protein concentrations were
determined by the bicinchoninic acid method (Pierce).
Immunoprecipitation and Western Blotting
For the immunoprecipitation studies, identical amounts of proteins
from each sample were clarified by a 1-h incubation at 4°C with a
mixture of protein A/Protein G Sepharose beads. After removal of
the Sepharose beads by low-speed centrifugation, the supernatants
were transferred to fresh tubes and incubated in lysis buffer over-
night at 4°C in the presence of 1 to 4 g/ml of a specific antibody.
With the exception of the agarose-conjugated anti-VEGFR-2 and
anti-caveolin antibodies, the immune complexes were collected by
incubating the mixtures with 25 l (50% suspension) of Protein A
(rabbit primary antibody) or Protein G (mouse primary antibody)
Sepharose beads. Nonspecifically bound proteins were removed by
washing the beads three times in 1 ml of lysis buffer containing 1
mM sodium orthovanadate, and bound material was solubilized in
25 l of twofold concentrated Laemmli sample buffer, boiled for 5
min, and resolved by SDS-PAGE. The proteins were transferred
onto polyvinylidene difluoride (PVDF) membranes, blocked over-
night at 4°C with Tris-buffered saline/Tween 20 (147 mM NaCl, 20
mM Tris-HCl, pH 7.5, and 0.1% Tween 20) containing 2% bovine
serum albumin and incubated with primary antibody for 2 h at
room temperature. Immunoreactive bands were revealed after a 1-h
incubation with horseradish peroxidase-conjugated anti-mouse or
anti-rabbit antibodies, and the signals were visualized with an ECL
detection system.
Migration Assay
Transwells (8-m pore size; Costar, Cambridge, MA) were pre-
coated with 0.5% gelatin/PBS by adding 600/100 l in the lower/
upper chambers for 24 h at 4°C. The transwells were then washed
with PBS and assembled in 24-well plates. The upper chamber of
each transwell was filled with 100 l of BAEC (1.0  106 cells/ml)
and cells were allowed to adhere for 1 h. Cells were then treated for
1 h by adding 100 l of 2 drug solution prepared in serum-free
L. Labrecque et al.
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DMEM in the upper chamber and 600 l of 1 drug solution in the
lower chamber. For cholesterol repletion, solution in the chambers
was aspirated and replaced by the CD/cholesterol preparation for
an additional 1 h. Migration was initiated by adding VEGF to the
lower chamber at a final concentration of 10 ng/ml and the plate
was placed at 37°C in 5% CO2/95% air for 2 h. Cells that had
migrated to the lower surface of the filters were fixed with 10%
formalin phosphate and stained with 0.1% Crystal Violet/20% (vol/
vol) methanol before being counted.
Transfection
cDNAs encoding VEGFR-2 (Patterson et al., 1995) and caveolin-1,
kindly provided by Dr S.-S. Yoon (Sung Kyon Kwan University,
Korea), were used to study the regulation of VEGFR-2 activity in an
heterologous system. 293T cells (6  105) were transiently trans-
fected with 2 g of cDNAs encoding VEGFR-2 and caveolin-1 using
the calcium phosphate precipitation method (Wigler et al., 1979).
Eighteen hours posttransfection, the culture medium was replaced
with fresh complete medium and, 48 h posttransfection, the 293T
cells were starved for 18 h with serum-free medium, harvested, and
used for immunoprecipitation assays. In some experiments, trans-
fected cells were stimulated with VEGF 50 ng/ml after starvation.
In Vitro Kinase Assay
Precleared cell lysates (500 g protein) were incubated overnight
with anti-VEGFR-2 antibodies, and the resulting immune com-
plexes were collected with Protein A-Sepharose beads as described
above. The beads were washed three times with lysis buffer, fol-
lowed by one additional wash with PBS. The washed beads were
then incubated for 1 h on ice with glutathione S-transferase (GST) or
GST-caveolin (61-101), in 40 l of kinase buffer (100 mM Tris-HCl,
pH 7.0, 0.2% -mercaptoethanol, 20 mM MgCl2, and 0.2 mM sodium
orthovanadate). After a 2-min preincubation of the mixtures at 30°C,
the reactions were initiated by the addition of 5 Ci of [-32P]ATP
(ICN Biochemicals, Costa Mesa, CA) or by the addition of 1 mM
nonradioactive ATP. Reactions were stopped after 15 min by the
addition of fivefold concentrated Laemmli sample buffer. After
electrophoresis on 7.5% acrylamide/bis-acrylamide gels, the gels
were exposed to Fuji films (Tokyo, Japan) or transferred onto PVDF
and subjected to Western blotting procedures.
Purification of GST-Caveolin(61-101)
The caveolin-1 scaffolding domain was constructed by polymerase
chain reaction (PCR) using the full-length caveolin-1 cDNA as the
template (gift of Dr. R. Venema) and primers annealing to the cDNA
regions encoding amino acids 61 through 101. The PCR product was
subcloned in the prokaryotic expression vector pGEX-2T and was
transformed into Escherichia Coli strain BL21. The GST-caveolin-1
scaffolding domain fusion proteins were purified from isopropyl--
d-thio-galactopyranoside-induced log phase bacterial cultures, fol-
lowed by affinity chromatography on glutathione-agarose beads.
RESULTS
Cofractionation of VEGFR-2, Caveolin-1, and
Signaling Proteins in Caveolae Membranes of
ECV304 and BAE Cells
VEGFR-2 has been previously reported to localize in caveo-
lae membranes of endothelial cells (Feng et al., 1999a, 1999b).
To establish whether these microdomains may represent
specialized signal transduction centers for VEGF-induced
signaling, caveolae membranes were purified from ECV304
cells, a spontaneously immortalized human umbilical vein
endothelial cell line (Figure 1, A and B), and from BAEC
(Figure 1, C and D) using the detergent-free method devel-
oped by Smart et al. (1995). Although the endothelial origin
of ECV304 cells has been recently questioned (Brown et al.,
2000), recent data show that these cells express various
endothelial characteristics not found in epithelial cells (Suda
et al., 2001). However, given their controversial nature,
ECV304 were used in this study only for the initial charac-
terization of the presence of VEGFR-2 in endothelial caveo-
lae.
Equal amounts of protein from whole cell lysates and
from the isolated caveolae membranes were separated by
SDS-PAGE electrophoresis, transferred onto PVDF mem-
branes, and probed using specific antibodies. As shown in
Figure 1, isolated membranes from both cell lines are char-
acterized by a significant enrichment in caveolae markers,
including caveolin-1, Ras, and the kinases Src and Fyn.
Interestingly, we also observed an enrichment of VEGFR-2
in both preparations as well as of proteins involved in the
regulation of VEGF-induced signaling pathways, such as v
and 3 integrin subunits (Borges et al., 2000), RhoA (Gingras
et al., 2000), eNOS (Papapetropoulos et al., 1997; Parenti et al.,
1998), and neuropilin-1 (Gitay-Goren et al., 1992; Figure 1).
By contrast, some proteins are not enriched in caveolae
membranes or are completely excluded from these domains,
Figure 1. Colocalization of
VEGFR-2 and numerous regula-
tory proteins in caveolae mem-
branes isolated from endothelial
cells. Caveolae membranes were
isolated from ECV304 cells (A and
B) or BAEC (C and D), after ultra-
centrifugation of plasma mem-
branes on Optiprep gradients
(Smart et al., 1995). Equivalent
amounts of proteins from the ly-
sates and purified membranes (5
g) were separated by SDS-PAGE
and were immunoblotted with
the indicated antibodies.
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including RhoB, FAK, -cop, and Cbl (Figure 1, B and D).
The absence of these proteins from caveolae purified from
other cell lines has been reported previously (Mastick and
Saltiel, 1997; Gingras et al., 1998; Demeule et al., 2000; Oh and
Schnitzer, 2001), and confirms the lack of contamination of
our preparations by Golgi (-cop), endosomal (rhoB), and
cytoskeletal (FAK) components.
To determine whether these cholesterol-rich microdomains
contain functional VEGFR-2, the caveolar membrane fraction
isolated from ECV304 cells was stimulated in vitro with VEGF.
Kinase activity has been already found in caveolae membranes
isolated by this method after treatment with epidermal growth
factor (EGF; Mineo et al., 1996) and platelet-derived growth
factor (PDGF; Liu et al., 1997). Accordingly, stimulation of the
caveolae membranes isolated from endothelial cells with VEGF
leads to a concentration-dependent increase in the tyrosine
phosphorylation of several membrane-associated proteins
(Figure 2A), the stimulatory effect being maximal at 50 to 100
ng/ml, as observed in whole cells (Gingras et al., 2000). This
stimulatory effect of VEGF seems to be associated exclusively
with the caveolae membranes because no VEGF-induced phos-
phorylation of noncaveolar membrane proteins could be de-
tected (Figure 2B). These results suggest that the initial steps of
VEGF-induced signalization are localized within caveolae do-
mains.
Cholesterol Depletion Modulates VEGFR-2
Localization and Signaling Activity
We next investigated whether the localization of VEGFR-2 to
endothelial caveolae was essential for its signaling activity.
Removal of cholesterol from cells has been shown to cause
the disassembly of caveolae and thus represents an interest-
ing tool for the study of caveolae-dependent processes
(Chang et al., 1992; Rothberg et al., 1992). We first tested
whether cholesterol depletion resulted in the removal of
VEGFR-2 from caveolae. BAECs were treated with CD, a
cholesterol-binding agent that extracts cholesterol from the
plasma membrane (Rodal et al., 1999; Ushio-Fukai et al.,
2001), and the resulting lysates were separated on sucrose
gradients (Figure 3). Under these conditions, the light-den-
sity caveolae membranes sedimented at the 5%/35% sucrose
interface (fractions 4 through 6). As shown in Figure 3A, CD
treatment of the cells resulted in the displacement of caveo-
lin-1 from caveolae to noncaveolae fractions (fractions 9
Figure 2. VEGF stimulates tyrosine phosphorylation of caveolae-
associated proteins. (A) Caveolae purified from ECV304 cells (250
ng) were stimulated 30 min on ice with the indicated concentrations
of VEGF, in the presence of phosphatase inhibitors. The phosphor-
ylation reaction was initiated by the addition of 1 mM ATP, and the
mixtures were incubated at 30°C for 5 min. Reactions were stopped
by the addition of fivefold concentrated Laemmli buffer and pro-
teins were separated by SDS-PAGE electrophoresis followed by
immunoblotting with a monoclonal anti-Tyr(P) antibody. (B)
Caveolae or noncaveolae membranes (250 ng) were incubated with
50 ng/ml VEGF and the phosphorylation reaction was performed as
described above. Results are representative of two experiments
performed with distinct caveolae preparations.
Figure 3. Cholesterol depletion of plasma membrane induces re-
localization of caveolin-1 and VEGFR-2. Serum-starved BAEC were
incubated for 1 h in the presence of 10 mM CD and subjected to
sucrose gradient sedimentation as described in “Material and Meth-
ods.” (A) Gradients were fractionated by collecting 1-ml fractions
from the top, and 20 l of each fraction was loaded onto polyacryl-
amide gels for the detection of caveolin-1. (B) Fractions correspond-
ing to caveolae-enriched membranes (fractions 4 through 6) were
diluted in Tris-HCl 10 mM (pH 7.5) and centrifuged at 100,000g.
Membranes were resuspended in lysis buffer, and equal quantities
of proteins were separated by SDS-PAGE electrophoresis.
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through 12; Figure 3A), this redistribution being also ob-
served for other caveolae-resident proteins such as Ras and
eNOS (L. Labrecque, D. Gringras, R. Beliveau, unpublished
data). To detect whether VEGFR-2 was removed from caveo-
lae, fractions corresponding to the light-density membranes
were pooled, concentrated, and immunoblotted with anti-
VEGFR-2 antibodies. As shown in Figure 4B, cholesterol
depletion resulted in the removal of VEGFR-2 from the
light-density membranes, supporting the disruption of the
molecular organization of the plasma membrane by CD
treatment.
We next investigated the effects of cholesterol depletion
on VEGF-induced signaling. We first observed that both
basal and VEGF-induced phosphorylation of VEGFR-2 were
markedly increased by CD treatment, and that the stimula-
tory effect of VEGF was maintained for a longer period of
time, resulting in increased tyrosine phosphorylation of
PLC-1, an important substrate that is tyrosine-phosphory-
lated by VEGFR-2 (Figure 4A, left panel; Guo et al., 1995).
The expression levels of all proteins was unaffected by the
treatment, supporting a specific alteration of kinase activity
by CD (Figure 4A, right panel). However, despite the hy-
perphosphorylation of VEGFR-2 and PLC, activation of
ERK was markedly reduced by CD, even although basal
phosphorylation of the enzymes was increased (Figure 4A).
Replenishment of cholesterol content, by incubation of the
cells in the presence of 16 g/ml cholesterol and 0.4% CD,
inhibited most of the stimulatory effect of CD because it
restored the initial low VEGF-induced VEGFR-2 and PLC
phosphorylation (Figure 4B). However, cholesterol replen-
ishment failed to restore VEGF-dependent activation of
ERK, suggesting additional alterations in downstream com-
ponents of the signaling pathway. These results demonstrate
that cholesterol is essential for proper spatiotemporal VEGF-
dependent cell signaling.
VEGF is known to be an important chemoattractant for EC
(Waltenberger et al., 1994). To evaluate the importance of
cholesterol-enriched domains for this biological activity, we
induced CD-treated BAEC to migrate on transwells in the
presence of VEGF as the chemoattractant. We observed a
considerable inhibition of VEGF-dependent migration in the
presence of CD, possibly reflecting the importance of plasma
membrane cholesterol in the migration of EC, as was re-
cently reported (Vincent et al., 2001). However, VEGF-in-
duced migration was significantly restored after cholesterol
repletion (Figure 4C). These results suggest that plasma
Figure 4. Cholesterol depletion
modulates VEGF-induced signal-
ing. (A) Serum-starved BAEC
were incubated for 1 h in the pres-
ence of 10 mM CD and were in-
cubated in the presence of 50
ng/ml VEGF for the indicated
times. Cells were lysed, subjected
to immunoprecipitation with the
indicated antibodies, and phos-
phorylation was monitored by
Western blotting using a specific
anti-Tyr(P) mAb. (B) After incu-
bation in the presence of 10 mM
CD, BAEC were treated for an ad-
ditional 1 h with 16 g/ml cho-
lesterol and 0.4% CD. Cells were
then stimulated with VEGF and
subjected to immunoprecipitation
with the indicated antibodies. (C)
BAEC were allowed to adhere in
transwells with gelatin-coated
membranes. Cells were treated as
indicated and migration was ini-
tiated by adding VEGF to the
lower chamber to a final concen-
tration of 10 ng/ml, and the plate
was placed at 37°C in 5% CO2/
95% air for 2 h. The number of
cells that crossed the membrane
were normalized to those from
nontreated cells.
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membrane caveolae integrity is essential for the proper re-
sponse of EC to VEGF.
Caveolin-1 Is a Negative Regulator of VEGFR-2
Activity
We further investigated the regulatory function of caveolae
on VEGF-dependent signaling by examining the effect of
caveolin-1 on VEGFR-2 activity. Caveolin-1 has emerged as
a key caveolae-associated protein that regulates the activity
of numerous signaling proteins (Schlegel et al., 2000b).
VEGFR-2 and caveolin-1 were cotransfected into 293T cells,
an human embryonic kidney cell line that expresses ex-
tremely low levels of endogenous caveolin-1 (Schlegel and
Lisanti, 2000a) and no VEGFR-2, and the extent of VEGFR-2
phosphorylation was examined. As shown in Figure 5A,
overexpression of VEGFR-2 in these cells, either in the pres-
ence or absence of caveolin-1, resulted in the localization of
VEGFR-2 to low-density membrane domains, suggesting
that the protein contains intrinsic structural motifs sufficient
for targeting to these domains. Under these conditions a
high and ligand-independent phosphorylation of the recep-
tor was observed, possibly due to high protein expression
levels that promote ligand-independent receptor dimeriza-
tion (Fuh et al., 1998). Interestingly, coexpression of caveo-
lin-1 and VEGFR-2 resulted in a marked inhibition of
VEGFR-2 activity (Figure 5B) that correlated with the colo-
calization of both proteins to the low-density domains (Fig-
ure 5A). Addition of VEGF to cells expressing both caveo-
lin-1 and VEGFR-2 induced a time-dependent increase in the
tyrosine phosphorylation of VEGFR-2, suggesting that stim-
ulation of the receptor with VEGF is able to circumvent the
inhibitory action of caveolin.
The inhibitory effect of caveolin-1 on the activity of several
signal-transducing proteins is mediated by the scaffolding
domain of caveolin-1, corresponding to residues 82 through
101 of the protein (Couet et al., 1997b; Engelman et al., 1998;
Yamamoto et al., 1999). We investigated the effect of this
domain, fused to GST, on VEGFR-2 activity using an in vitro
kinase assay. VEGFR-2 was immunoprecipitated from cell
lysates, and the immune complexes were preincubated in
the presence of increasing amounts of GST-cav (61-101) or
GST. The extent of VEGFR-2 activity was monitored either
Figure 5. Cotransfection of
VEGFR-2 and caveolin-1 in hu-
man embryonal kidney cells in-
hibits receptor autophosphoryla-
tion. 293T cells were transiently
transfected with VEGFR-2 and
caveolin-1 cDNAs, using the cal-
cium phosphate precipitation
procedure (Wigler et al., 1979).
Forty-eight hours posttransfec-
tion, cells were serum-starved
and lysed. (A) Caveolae mem-
branes were purified using the
hyperosmotic carbonate method
(Song et al., 1996). Fractions were
separated by SDS-PAGE electro-
phoresis, blotted, and tested for
caveolin-1 or VEGFR-2, as indi-
cated. (B and C) VEGFR-2 was
immunoprecipitated from cell ex-
tracts (350 g) and phosphoryla-
tion was monitored by immuno-
blotting with a monoclonal anti-
Tyr(P) antibody. In C, cells were
treated with 50 ng/ml VEGF for
the periods indicated before lysis.
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by incubating the complexes with [-32P]ATP (Figure 6A) or
with 1 mM ATP, followed by antiphosphotyrosine detection
(Figure 6B). As shown in Figure 6, the addition of the GST-
cav(61-101) fusion protein caused a dose-dependent inhibi-
tion of VEGFR-2 autophosphorylation in both assays,
whereas GST had no effect. This suggests that the caveolin-1
negative regulation of VEGFR-2 activity is likely to be me-
diated by the scaffolding domain of the protein.
VEGFR-2 Is Associated with Caveolin-1
A consensus sequence for proteins that bind to caveolin has
been identified in the kinase domains of several RTK asso-
ciated with caveolae domains (Couet et al., 1997b). Close
examination of the VEGFR-2 sequence indicates that the
protein contains a putative caveolin-binding motif in its
kinase domain (1091WSFGVLLWEIF1101). Based on the ob-
served inhibition of VEGFR-2 activity by caveolin-1, we thus
examined the possibility of an association between the pro-
teins. VEGFR-2 from lysates isolated from unstimulated or
from VEGF-stimulated BAEC were immunoprecipitated
and the presence of caveolin-1 in the immune complexes
was monitored by immunoblotting. In unstimulated BAEC,
we observed the coprecipitation of caveolin-1 with VEGFR-2
(Figure 7A; 0 min). Interestingly, the stimulation of BAEC
with VEGF induced a rapid, time-dependent dissociation of
caveolin-1 from VEGFR-2, this dissociation being nearly
complete 15 min after the addition of VEGF. The association
of caveolin-1 with VEGFR-2 was enriched in isolated caveo-
lae domains (Figure 7B), but was markedly reduced after
cholesterol depletion, suggesting that the protein association
requires the integrity of these domains (Figure 7C). These
results indicate that under resting conditions, caveolin-1
may act as a negative regulator of VEGFR-2 activity and that
stimulation of the receptor by VEGF may promote activation
of this signaling pathway by inducing the dissociation of the
receptor from the inhibitory action of caveolin-1.
Caveolin-1 Is Tyrosine Phosphorylated after
Stimulation of BAEC with VEGF
Caveolin-1 has been shown to be tyrosine phosphorylated in
response to stimulation of cells with EGF and insulin (Ma-
stick et al., 1995; Kim et al., 2000). Based on the presence of
VEGFR-2 in caveolae and on the inhibitory effect of caveo-
lin-1 on its activity, we next investigated the extent of caveo-
lin-1 phosphorylation induced by VEGF stimulation. Addi-
tion of VEGF to BAEC leads to a marked increase in the
tyrosine phosphorylation of caveolin-1, this effect being pre-
dominantly observed for the  isoform of caveolin-1 (caveo-
lin-1) as compared with the  isoform (caveolin-1), which
lacks the first 32 amino acids (Figure 8A). The phosphory-
lation of caveolin on tyrosine 14 shows kinetics similar to
those of caveolin-1 phosphorylation, reaching a maximum
after a 2-min incubation with VEGF, suggesting that caveo-
lin-1 is phosphorylated at this residue (Figure 8A). Interest-
ingly, caveolin-1 phosphorylation follows the kinetics of
VEGFR-2 activation (Figure 8A), and the maximal induction
of caveolin-1 and VEGFR-2 phosphorylation correlated with
the observed VEGF-induced dissociation of caveolin-1 from
VEGFR-2 (Figure 7A), suggesting that caveolin-1 is a sub-
strate for VEGFR-2 or for a kinase activated by VEGFR-2.
These results suggest that VEGFR-2 activation, after its dis-
sociation from caveolin-1, leads to caveolin-1 phosphoryla-
tion. In this respect, we observed that CD treatment of
BAEC, which removes VEGFR-2 from caveolae and induces
its dissociation from caveolin-1, induced a massive tyrosine
phosphorylation of caveolin-1 (Figure 8B).
Figure 6. The caveolin-1 scaffolding domain inhibits the in vitro
kinase activity of VEGFR-2. Immunoprecipitated VEGFR-2 from
serum-starved BAEC was incubated for 1 h on ice in the presence of
GST or GST-Caveolin-161–101 and submitted to an in vitro kinase
assay in the presence of 5 Ci of ATP (-32P) (A) or in the presence
of nonradioactive ATP at a final concentration of 1 mM (B). After 15
min at 30°C, reactions were stopped by the addition of fivefold
concentrated sample buffer. After electrophoresis on 7.5% acryl-
amide/bis-acrylamide gels, the gels were exposed to Fuji films (A)
or transferred onto PVDF and subjected to Western blotting (B).
Figure 7. VEGF induces dissociation of caveolin-1 from VEGFR-2.
(A) BAEC were serum-starved overnight and incubated in the pres-
ence of 50 ng/ml VEGF for the indicated times. After a 1 h sodium
orthovanadate treatment, cells were lysed (700 g) and subjected to
immunoprecipitation with agarose-conjugated anti-VEGFR-2. Associ-
ated caveolin-1 was observed by Western blotting using a specific
mAb. (B) After VEGF stimulation, caveolae membranes were prepared
and fractions corresponding to caveolae-enriched membranes were
diluted and concentrated by ultracentrifugation. Equal quantities of
proteins were used for immunoprecipitation assays. (C) Before VEGF-
stimulation, cells were incubated for 1 h in the presence of 10 mM CD.
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Although caveolin-1 possesses several tyrosine residues
that are known to be phosphorylated (Nomura and Fujimito,
1999), the main site of phosphorylation has been shown to
occur on tyrosine 14 of the protein and is catalyzed by
members of the Src family kinases (SFK; Li et al., 1996). We
thus examined the effects of SFK inhibition on the VEGF-
dependent caveolin-1 tyrosine phosphorylation. As shown
in Figure 8C, incubation of BAEC with PP2, an inhibitor of
SFK, completely abolished VEGF-induced caveolin-1 phos-
phorylation. This effect was not related to a non specific
inhibitory effect on VEGFR-2 kinase activity because VEGF-
dependent phosphorylation of the receptor was not inhib-
ited under these conditions (Figure 8C). In fact, we consis-
tently observed a slight increase in the phosphorylation of
VEGFR-2 after treatment of the cells with PP2 (Figure 8C).
Overall, these results suggest that caveolin-1 is phosphory-
lated after VEGF-dependent activation of VEGFR-2; this
phosphorylation possibly occurs in the N-terminal region of
the protein and involves activation of Src family kinases.
VEGF Induces the Association of Caveolin-1
with Src
Src has recently been shown to play an essential role in the
VEGF-dependent activation of EC, possibly through its
phosphorylation of FAK (Abu-Ghazaleh and al., 2001), re-
sulting in the coupling of this enzyme to the v5 integrin
(Eliceiri and al., 2002). However, this activation appears to
be transient because phosphorylation of FAK is maximal at
2 to 5 min and rapidly declines afterward (Eliceiri et al.,
2002). Because caveolin is known to interact preferentially
with the inactive conformation of Src (Li et al., 1996), we
were interested in determining whether the inhibition of Src
activity during longer incubation times correlated with an
association of the kinase with caveolin-1. As shown in Fig-
ure 9A, the stimulation of BAEC with VEGF promoted a
time-dependent association of Src with caveolin-1, maximal
association occurring at 20 min, which corresponds tempo-
rally with the down-regulation of its activity (Eliceiri et al.,
2002). We further observed that 20 min after the addition of
VEGF, Src is predominantly phosphorylated on Y527 (Fig-
ure 9B), which reflects the inactive status of the kinase
(Brown and Copper, 1996). Another member of the Src ki-
nases, Fyn, was also associated with caveolin-1 under rest-
ing conditions, but the degree of association was unaffected
by VEGF. These results suggest that VEGF treatment in-
duces a rapid but transient activation of Src, followed by
inactivation of the enzyme and its association with caveo-
lin-1.
DISCUSSION
The targeting of VEGFR-2 activity as a mean of blocking
angiogenesis and tumor growth has received considerable
attention in recent years (Schlaeppi and Wood, 1999). Al-
though the signaling pathways triggered by this important
receptor are becoming increasingly understood (Matsumoto
and Claesson-Welsh, 2001), there are still considerable gaps
in our knowledge of the mechanisms involved in the regu-
lation of the activity of VEGFR-2 as well as their relationship
to tumor angiogenesis. In this respect, we were intrigued by
Figure 8. VEGF induces Src-dependent tyrosine phosphorylation
of caveolin-1. (A) BAEC were serum-starved 18 h and incubated in
the presence of 50 ng/ml VEGF for the indicated times. After a 1-h
sodium orthovanadate treatment, cells were lysed and subjected to
immunoprecipitation with agarose-conjugated anti-caveolin-1 (350
g of cell lysate) or anti-VEGFR-2 (200 g). Incubation of BAEC was
also performed before VEGF stimulation in the presence of 10 mM
CD (B) or 10 M PP2 (C). Phosphorylation was monitored by
Western blotting using a specific anti-Tyr(P) mAb.
Figure 9. VEGF induces association of Src to caveolin-1. BAEC
were serum-starved overnight and incubated in the presence of 50
ng/ml VEGF for the indicated times. After a 1-h sodium orthovana-
date treatment, cells were lysed (700 g) and subjected to immuno-
precipitation with agarose-conjugated anti-caveolin-1. Associated
caveolin-1 was observed by Western-blotting with a specific mAb.
(B) After lysis, Src was immunoprecipitated and Western blotted
using a specific antibody against the form of Src phosphorylated on
tyrosine 527.
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recent reports showing the potential involvement of caveo-
lae in the regulation of angiogenesis (Liu et al., 1999), which
were subsequently strengthened by results showing that
gene disruption of caveolin-1 results in uncontrolled EC
proliferation in vivo (Razani et al., 2001), and that reduction
of caveolin-1 levels by antisense oligonucleotides results in
impaired angiogenesis in vitro (Griffoni et al., 2000). These
considerations led us to investigate the localization and
regulation of VEGFR-2 activity in endothelial caveolae. In
this study, we report that endothelial caveolae-enriched
membrane domains are highly enriched in both VEGFR-2
and in a number of proteins that have been shown to par-
ticipate in the VEGF signal transduction pathways, such as
v3 integrin (Borges et al., 2000), eNOS (Papapetropoulos et
al., 1997; Parenti et al., 1998), and RhoA (Gingras et al., 2000).
Such compartmentization has been shown to be crucial for
several signaling pathways, such as those triggered by EGF
(Mineo et al., 1996) and PDGF (Liu et al., 1996), possibly
allowing efficient interactions between key signaling pro-
teins that are required for both positive and negative regu-
lation of these activities. Moreover, we observed that the
isolated caveolae membranes undergo a significant increase
in tyrosine phosphorylation when incubated in the presence
of VEGF, demonstrating that the first steps of VEGF-induced
signaling could be initiated in these domains. Interestingly,
overexpression of VEGFR-2 in cells lacking caveolin-1 re-
sulted in its targeting to low-density domains, suggesting
that the protein contains intrinsic features that allow its
targeting to these domains. This further emphasizes the
important role of localization for the proper function of the
receptor.
The integrity of caveolae structure seems to be important
for accurate VEGF-induced signaling. Cholesterol depletion
of EC by CD, which leads to the loss of caveolae structure as
observed by transmission electron microscopy of the plasma
membrane (Parpal et al., 2001), induced the relocalization of
both caveolin-1 and VEGFR-2 to high-density membranes.
This was accompanied by an increase in VEGFR-2 and
PLC-1 phosphorylation, possibly due to reduced associa-
tion between VEGFR-2 and caveolin-1 (Figure 7C). This is in
agreement with the observed absence of caveolae in trans-
formed cells (Koleske et al., 1995), which are also character-
ized by an increase in signaling events. Similar results were
observed with vascular smooth muscle cells, where CD
caused an increase in EGF-induced EGF receptor phosphor-
ylation (Ushio-Fukai et al., 2001), but not in Rat-1 cells, in
which EGF receptor phosphorylation was not affected by CD
(Furuchi and Anderson, 1998), nor in the activation of the
insulin receptor in 3T3-L1 adipocytes (Parpal et al., 2001).
Thus, it seems that caveolae and caveolin-1 lead to different
actions depending on the cell type and stimuli. However,
our results show that despite hyperphosphorylation of up-
stream components of the signaling cascade, the disassem-
bly of caveolae structures by cholesterol depletion inhibits
VEGF-induced EC migration. It is likely that inadequate
localization of the signaling machinery outside of caveolae
could prevent proper continuation of the signal, a hypothe-
sis supported by the observation that CD treatment results
in reduced VEGF-dependent ERK activation (Figure 4A).
One important observation of this study is that, under
resting conditions, caveolin-1 is associated with the inactive
form of VEGFR-2 and undergoes rapid dissociation from the
receptor upon stimulation with VEGF. This association of
caveolin-1 is inhibitory to VEGFR-2 activity, based on the
observation that coexpression of both proteins in a heterol-
ogous system results in the inhibition of receptor activity, as
well as by the correlation between the kinetics of caveolin-1
dissociation and VEGFR-2 activation in response to VEGF.
The inhibitory action of caveolin-1 likely involves interac-
tion of its scaffolding domain with a putative consensus
caveolin-1-binding motif located in the kinase domain of the
receptor, as reflected by the inhibitory effect of this domain
on the in vitro autophosphorylation activity of the receptor.
It is tempting to speculate that the interaction of caveolin-1
with VEGFR-2 may be crucial for normal cell function based
on the observation that disruption of the caveolin-1 gene
leads to uncontrolled EC proliferation (Razani et al., 2001).
In addition to its inhibitory action on VEGFR-2 activity,
our study also provides evidence that caveolin-1 may fulfill
other functions in the signaling pathways triggered by
VEGF. Stimulation of EC with VEGF resulted in a marked
increase in the tyrosine phosphorylation of caveolin-1,
which correlated with the kinetics of VEGFR-2 activation. A
portion of the VEGF-dependent tyrosine phosphorylation of
caveolin-1 occurred on tyrosine 14 of the protein, which is
recognized as the principal residue phosphorylated by Src
kinases (Li et al., 1996). Accordingly, VEGF-dependent phos-
phorylation of caveolin-1 was inhibited by pharmacological
inhibitors of Src kinases, suggesting that these enzymes may
be responsible for the caveolin-1 phosphorylation induced
by activation of VEGFR-2. An important role for Src kinases
in VEGF-induced signaling pathways was recently de-
scribed (Eliceiri et al., 1999) and seems to be related to the
phosphorylation of the focal adhesion kinase (Abu-Ghaza-
leh et al., 2001), possibly resulting in the interaction of this
enzyme with the v5 integrin (Eliceiri et al., 2002) Whether
tyrosine phosphorylation of caveolin-1 by Src plays a role in
these processes remains to be determined.
The role of caveolin-1 phosphorylation in cell function
remains unclear but seems important. Under normal condi-
tions, caveolin-1 has been shown to be phosphorylated in
response to growth factors such as EGF and insulin (Kim et
al., 2000). Inactivation of Src kinases, either by specific in-
hibitors such as PP1 (Lee et al., 2000) and PP2 (Li et al., 1996)
or by transfection of dominant negative versions of the
kinase (Volonte et al., 2001), inhibits caveolin-1 phosphory-
lation induced by EGF, insulin, or cellular stress, further
emphasizing the important roles of these kinases in caveo-
lin-1 phosphorylation. Tyrosine-phosphorylated caveolin-1
appears to be localized at focal adhesion sites, which are
major sites of tyrosine kinase signaling in vivo, suggesting
that it may exert important functions in signaling. Such an
important role is supported by the specific interaction of
phosphocaveolin with Grb7, during growth factor-induced
cell migration (Lee et al., 2000), and with the low-molecular-
weight protein-tyrosine phosphatase involved in the down-
regulation of PDGF and insulin receptors (Caselli et al.,
2001). However, caveolin-1 phosphorylation seems to be cell
type- and stimulus-specific because it was not observed in
adrenal cortex EC after VEGF stimulation (Esser et al., 1998)
nor in BAEC under shear stress condition (Fujioka et al.,
2000), even though this phosphorylation was similarly dem-
onstrated in NIH 3T3 cells (Volonte et al., 2001).
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The mechanisms involved in the VEGF-dependent phos-
phorylation of caveolin-1 by Src kinase remain obscure.
Association of caveolin-1 with Src-family kinases has also
been reported in the signaling pathway required for albu-
min endocytosis and transcytosis, where activation of an EC
membrane albumin-binding protein (gp60) induced caveo-
lin-1 phosphorylation and association with kinases Src and
Fyn (Tiruppathi et al., 1997). Thus, VEGFR-2/caveolin-1 as-
sociation could be mediated using Src as an intermediary, as
was suggested for the insulin-stimulated tyrosine phosphor-
ylation of caveolin-1 (Mastick and Saltiel, 1997). However,
the VEGFR-2 protein lacks consensus binding sites for Src
SH2 domains (Matsumoto and Claesson-Welsh, 2001) and
we were unable to detect the association of Src with
VEGFR-2 under our experimental conditions, although this
has recently been suggested (He et al., 1999). Whether caveo-
lin-1 phosphorylation involve its interaction with other com-
ponents, such as integrin  subunits (Wary et al., 1998), is
currently under investigation.
Cholesterol depletion also induced hyperphosphorylation
of caveolin-1 (Figure 8B). In v-Src-expressing cells, caveo-
lin-1 phosphorylation is associated with flattening and ag-
gregation of caveolae (Nomura and Fujimoto, 1999). Thus,
caveolin-1 phosphorylation could be involved in the inter-
nalization of caveolae in response to stimuli. This could
explain the observed augmentation of VEGFR-2 phosphor-
ylation after PP2 treatment (Figure 8C) where internaliza-
tion, or down-regulation mechanisms, are inhibited and
hence the receptor remains at the cell surface for a longer
period of time, resulting in its hyperphosphorylation. The
mechanisms leading to down-regulation of VEGFR-2 are not
well understood. Although the clathrin-coated pits/vesicle
system is still the best known system for the degradation
and recycling of receptors, recent evidence has pointed out
caveolae domains as an alternative internalization pathway
involving fusion of caveolae with the early/sorting endo-
cytic compartment, where the phosphorylation of Raf-1,
Mek, and eventually MAPK could be achieved (Pol et al.,
1998, 2000). In agreement with this model, EGF receptors
rapidly move out of caveolae domains after EGF stimulation
in quiescent fibroblasts (Mineo et al., 1999), and VEGF-stim-
ulation induces nuclear translocation of VEGFR-2 in BAEC
and in bovine retinal endothelial cells (Feng et al., 1999a).
In addition to its role as both a regulator of VEGFR-2 and
as a substrate of VEGFR-2-activated Src kinase, our results
also suggest that caveolin-1 interacts with inactive Src after
stimulation of the cells with VEGF. Under the conditions
used here, this interaction is a late event in this cascade
because it reached a maximum after 20 min, well after the
peaks of VEGFR-2 and caveolin-1 phosphorylation. The in-
teraction of caveolin-1 with Src correlated with the VEGF-
dependent tyrosine phosphorylation of Src on tyrosine 527,
a major site of Src phosphorylation by C-terminal Src kinase
(Csk) that results in inactivation of Src (Erpel and Courtnei-
dge, 1995). However, under our experimental conditions, we
were unable to determine whether caveolin-1-associated Src
was phosphorylated on tyrosine 527, due to the low levels of
Src in the immune complexes. Although the mechanisms
involved in this interaction remain to be clarified, it is note-
worthy that Csk was recently shown to interact preferen-
tially with caveolin-1, which is phosphorylated on tyrosine
14, which may provide a mechanism for its recruitment to
caveolae membranes and allow the subsequent inactivation
of Src by phosphorylation (Cao et al., 2002).
In summary, our results show that caveolae domains and
its resident protein caveolin-1 may play multiple roles in the
regulation of VEGFR-2 activity and of angiogenesis. Caveo-
lin-1 inhibits basal VEGFR-2 activity through the formation
of a molecular complex that rapidly dissociates upon stim-
ulation by VEGF, enabling caveolin-1 to serve as a substrate
for Src kinases. Moreover, caveolin-1 may serve as an addi-
tional regulatory component of the pathway by sequestering
Src in its inactive conformation. These results emphasize a
complexity and versatility of caveolin-1 in the VEGF-in-
duced signaling pathway that are consistent with recent
results showing that caveolin-1 is down-regulated during
EC proliferation (Liu et al., 1999) but is up-regulated during
their differentiation into tubular networks in vitro (Liu et al.,
2002). Thus, the recognition of caveolin-1 as both a negative
and positive regulator of angiogenesis through its interac-
tion with both upstream and downstream components of
the VEGF-induced signaling cascade may provide interest-
ing new tools for the study of the role of this protein in
angiogenesis.
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